药品注册申请号:019853
申请类型:NDA (新药申请)
申请人:VALEANT PHARMS INTL
申请人全名:VALEANT PHARMACEUTICALS INTERNATIONAL
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CUPRIMINE PENICILLAMINE CAPSULE;ORAL 250MG Yes Yes AB 1970/12/04 Approved Prior to Jan 1, 1982 Prescription
002 CUPRIMINE PENICILLAMINE CAPSULE;ORAL 125MG No No None Approved Prior to Jan 1, 1982 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2004/10/26 SUPPL-14(补充) Approval Labeling STANDARD
2004/10/26 SUPPL-12(补充) Approval Labeling STANDARD
2003/11/20 SUPPL-11(补充) Approval Labeling STANDARD
2003/11/20 SUPPL-7(补充) Approval Labeling STANDARD
2003/05/27 SUPPL-13(补充) Approval Labeling STANDARD
1996/03/01 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1994/08/18 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
1989/01/09 SUPPL-4(补充) Approval Labeling
1989/01/05 SUPPL-3(补充) Approval Labeling
1988/10/04 SUPPL-5(补充) Approval Manufacturing (CMC) STANDARD
1987/08/25 SUPPL-2(补充) Approval Labeling
1987/08/21 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1970/12/04 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PENICILLAMINE 剂型/给药途径:CAPSULE;ORAL 规格:250MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019853 001 NDA CUPRIMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 VALEANT PHARMS INTL
209921 001 ANDA LUXZYLA PENICILLAMINE CAPSULE;ORAL 250MG Discontinued No No AB 2019/05/07 ANI PHARMS
210976 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2019/06/24 WATSON LABS INC
211231 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2019/12/23 ENDO OPERATIONS
213310 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2020/04/28 APOTEX
211867 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2020/08/04 DR REDDYS
211735 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2020/12/02 GRANULES
213293 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2021/08/19 INVAGEN PHARMS
215409 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2021/08/23 BRECKENRIDGE
214363 001 ANDA PENICILLAMINE PENICILLAMINE CAPSULE;ORAL 250MG Prescription No No AB 2021/10/08 NAVINTA LLC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database